Hereditary Angioedema - Type 1 Clinical Trials

7 clinical trials for Hereditary Angioedema - Type 1 across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema — RECRUITING · PHASE2
• Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE) — RECRUITING · PHASE3
• STOP-HAE: A Phase 3 Study of ADX-324 in HAE — RECRUITING · PHASE3
• Real-life Ecological Momentary Assessment of Lived Burden in Hereditary AngioEdema — RECRUITING
• Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema — COMPLETED · PHASE2
• Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema — COMPLETED · PHASE3
• Dose-ranging Study of Oral PHA-022121 for Prophylaxis Against Angioedema Attacks in Patients With Hereditary Angioedema Type I or Type II — COMPLETED · PHASE2

Refine this search